Retinoic acid inhibitors mitigate vision loss in a mouse model of retinal degeneration.
Michael TeliasKevin K SitDaniel FrozenfarBenjamin E SmithArjit MisraMichael J GoardRichard H KramerPublished in: Science advances (2022)
Rod and cone photoreceptors degenerate in retinitis pigmentosa (RP). While downstream neurons survive, they undergo physiological changes, including accelerated spontaneous firing in retinal ganglion cells (RGCs). Retinoic acid (RA) is the molecular trigger of RGC hyperactivity, but whether this interferes with visual perception is unknown. Here, we show that inhibiting RA synthesis with disulfiram, a deterrent of human alcohol abuse, improves behavioral image detection in vision-impaired mice. In vivo Ca 2+ imaging shows that disulfiram sharpens orientation tuning of visual cortical neurons and strengthens fidelity of responses to natural scenes. An RA receptor inhibitor also reduces RGC hyperactivity, sharpens cortical representations, and improves image detection. These findings suggest that photoreceptor degeneration is not the only cause of vision loss in RP. RA-induced corruption of retinal information processing also degrades vision, pointing to RA synthesis and signaling inhibitors as potential therapeutic tools for improving sight in RP and other retinal degenerative disorders.
Keyphrases
- rheumatoid arthritis
- disease activity
- optical coherence tomography
- diabetic retinopathy
- ankylosing spondylitis
- mouse model
- endothelial cells
- induced apoptosis
- interstitial lung disease
- optic nerve
- systemic lupus erythematosus
- loop mediated isothermal amplification
- signaling pathway
- high resolution
- working memory
- label free
- real time pcr
- high glucose
- cell death
- cell cycle arrest
- drug induced
- skeletal muscle
- systemic sclerosis
- metabolic syndrome
- mass spectrometry
- photodynamic therapy
- spinal cord injury
- cell proliferation
- insulin resistance
- idiopathic pulmonary fibrosis
- binding protein